REG - MyCelx Tech. Corp. MyCelx Tech. Corp.. - Block listing Interim Review

Mycelx TechnologiesAnnouncement

11/06/2019 07:00

RNS Number : 7460B
MyCelx Technologies Corporation
10 June 2019
 


MyCelx Technologies Corporation
("MYCELX" or the "Company") (AIM: MYX)
 
11 June 2019
 
 
 
Block Admission Interim Update
 
In respect of the block admissions to trading on AIM on 29 April 2013 and 3 October 2017 for MYCELX common shares of US$0.025 each ("Shares"), MYCELX provides the following update in respect of the period 7 December 2018 to 10 June 2019 to (the "Period").
 
 
Omnibus Performance Incentive Plan 2011                            No of Shares                    
                                   
Admitted on 29 April 2013                                              300,000
Admitted on 3 October 2017                                          300,000
Issued prior to the Period                                              (333,198)
Issued during the Period                                                 (32,500)
                                                                                                   ------------
Shares not yet issued                                                                 234,302
                                                                                                   =======
 
 
 
 
Enquiries:
 
MYCELX Technologies Corporation                                                   +1 888 306 6843
Kimberly Slayton, Chief Financial Officer
 
Cantor Fitzgerald Europe
Nominated Adviser and Broker
David Porter
Richard Salmond                                                                                 +44 207 894 7000
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRBCGDLSXBBGCG